Work

A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.9538

Authors: Anna C. Pavlick, Ana Blazquez, Marcia Meseck, Michael J. Donovan, Mireia Castillo-Martin, Tin Htwe Thin, Rachel Sabado, John P. Mandeli, Sacha Gnjatic, Philip Adam Friedlander, Nina Bhardwaj

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Icahn School of Medicine at Mount Sinai, Genentech, Tisch Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947234872

Cites:

Cited by: 5

Related to: 10